Leading brokerage firms have released their latest recommendations, highlighting key stocks poised for potential growth. Reliance Industries, HDFC Life, Mahindra & Mahindra (M&M), Bharti Airtel, and Bajaj Finance are among the top picks in the latest reports.
Key Buy Calls:
-
Reliance Industries received a positive outlook from:
- Jefferies: Maintain Buy, Target Price: ₹1,600
- Kotak: Upgrade to Buy, Target Price: ₹1,400
-
HDFC Life – BofA: Maintain Buy, Target Price: ₹875
-
Mahindra & Mahindra (M&M) – BofA: Maintain Buy, Target Price: ₹3,650
-
Bharti Airtel received strong backing from:
- BofA: Maintain Buy, Target Price: ₹2,085
- HSBC: Maintain Buy, Target Price: ₹1,985
-
Bajaj Finance – BofA: Maintain Buy, Target Price: ₹9,350
Other Notable Buy Ratings:
- Larsen & Toubro (L&T): BofA: ₹4,150
- Axis Bank: BofA: ₹1,300
- ICICI Bank: BofA: ₹1,500
- Infosys: BofA: ₹2,150
- Divi’s Laboratories: BofA: ₹6,850
- Eicher Motors: BofA: ₹6,000
- Cholamandalam Investment: Jefferies: ₹1,700
Sector Outlook & Market Trends:
- Morgan Stanley highlighted improving liquidity and easing regulatory challenges, making Axis Bank, ICICI Bank, HDFC Bank, and Kotak Bank attractive picks.
- Jefferies noted India’s positioning by emerging market (EM) funds is at a decadal low, keeping the outlook neutral.
Neutral & Reduce Ratings:
- Vodafone Idea: HSBC: Reduce, Target Price: ₹6.5
- Polycab: Goldman Sachs: Neutral, Target Price: ₹3,780
- Sun Pharma: HSBC: Neutral, Target Price cut to ₹2,000
- BSE Ltd: Goldman Sachs: Neutral, Target Price cut to ₹4,230
With strong buy calls in banking, telecom, and infrastructure, markets may see bullish momentum in these sectors. However, concerns in telecom and select pharma stocks signal a mixed outlook.
Disclaimer: The information provided in this article is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any securities. Stock market investments are subject to risks, and past performance is not indicative of future results. Readers are advised to conduct their own research and consult with a qualified financial advisor before making any investment decisions. Business Upturn and its affiliates are not responsible for any financial losses incurred due to investment decisions based on this article.